Medtronic Reiterates FY23 Outlook - Update
(RTTNews) - While reporting financial results for the first quarter on Tuesday, medical devices maker Medtronic plc. (MDT) reiterated its adjusted earnings and revenue growth guidance for the full-year 2023.
For fiscal 2023, the company still projects adjusted earnings in a range of $5.53 to $5.65 per share, which includes an estimated 17 to 22 cent negative impact from foreign currency, on organic revenue growth of 4 to 5 percent. On average, analysts polled by Thomson Reuters expect the company to report earnings of $5.56 per share on revenue growth of 0.8 percent to $31.94 billion for the quarter. Analysts' estimates typically exclude special items.
"Looking ahead, we expect organic revenue growth to improve each quarter, with the second half of the fiscal year much stronger than the first. We are optimistic about our future, as we create markets and realize new opportunities," said Karen Parkhill, Medtronic chief financial officer.
Medtronic Guides FY25 Adj. EPS In Line With Estimates; Boosts Dividend - Update
Medtronic Files Complaint Against Axonics With US ITC For Two Patent Infringements
Medtronic Boosts FY24 Outlook - Update
Medtronic Says Inceptiv Spinal Cord Stimulator With Closed-loop Sensing Gets CE Mark Approval
Medtronic Guides FY24 Adj. EPS Below View: Boosts Dividend - Update
Medtronic Boosts FY23 Adj. EPS Outlook - Update
Medtronic Inks Co-promotion Deal With Israeli Privately-held Company CathWorks
